NO301162B1 - Imidazolylpyridinderivater - Google Patents

Imidazolylpyridinderivater Download PDF

Info

Publication number
NO301162B1
NO301162B1 NO923653A NO923653A NO301162B1 NO 301162 B1 NO301162 B1 NO 301162B1 NO 923653 A NO923653 A NO 923653A NO 923653 A NO923653 A NO 923653A NO 301162 B1 NO301162 B1 NO 301162B1
Authority
NO
Norway
Prior art keywords
acid addition
free base
addition salt
compound
alkyl
Prior art date
Application number
NO923653A
Other languages
English (en)
Norwegian (no)
Other versions
NO923653L (no
NO923653D0 (no
Inventor
Rudolf Karl Andreas Giger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO923653D0 publication Critical patent/NO923653D0/no
Publication of NO923653L publication Critical patent/NO923653L/no
Publication of NO301162B1 publication Critical patent/NO301162B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO923653A 1991-09-23 1992-09-21 Imidazolylpyridinderivater NO301162B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4131584A DE4131584A1 (de) 1991-09-23 1991-09-23 Imidazolylmethyl-pyridine, ihre herstellung und anwendung als pharmazeutika

Publications (3)

Publication Number Publication Date
NO923653D0 NO923653D0 (no) 1992-09-21
NO923653L NO923653L (no) 1993-03-24
NO301162B1 true NO301162B1 (no) 1997-09-22

Family

ID=6441240

Family Applications (1)

Application Number Title Priority Date Filing Date
NO923653A NO301162B1 (no) 1991-09-23 1992-09-21 Imidazolylpyridinderivater

Country Status (24)

Country Link
EP (1) EP0534904B1 (da)
JP (1) JP2568356B2 (da)
KR (1) KR100254085B1 (da)
AT (1) ATE144509T1 (da)
AU (1) AU650569B2 (da)
CA (1) CA2078700C (da)
CZ (1) CZ281675B6 (da)
DE (2) DE4131584A1 (da)
DK (1) DK0534904T3 (da)
ES (1) ES2092666T3 (da)
FI (1) FI103887B1 (da)
GR (1) GR3021444T3 (da)
HU (2) HUT61993A (da)
IL (1) IL103229A (da)
MX (1) MX9205365A (da)
MY (1) MY110450A (da)
NO (1) NO301162B1 (da)
NZ (1) NZ244420A (da)
RO (1) RO109337B1 (da)
RU (1) RU2058312C1 (da)
SG (1) SG43079A1 (da)
SK (1) SK289692A3 (da)
TW (1) TW222630B (da)
ZA (1) ZA927279B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10165349A (ja) * 1996-12-06 1998-06-23 Matsushita Electric Ind Co Ltd 食器洗浄機
DE10000161A1 (de) * 2000-01-06 2001-07-19 Boehringer Ingelheim Pharma Verfahren zur Identifikation eines Proteaseinhibitors
GB0009037D0 (en) * 2000-04-13 2000-05-31 Novartis Ag Organic compounds
BRPI0614701A2 (pt) * 2005-07-29 2011-04-12 Vanda Pharmaceuticals Inc usos de um composto para melhorar a vigìlia e composições farmacêuticas
MX2008010322A (es) * 2006-02-13 2009-03-05 Vanda Pharmaceuticals Inc Formulaciones de dosificacion estable de imidazolilalquil-piridina s.
WO2009097416A1 (en) * 2008-01-29 2009-08-06 Vanda Pharmaceuticals, Inc. Imidazolylalkyl- pyridines as dbh inhibitors
CN102245625A (zh) 2008-10-17 2011-11-16 威斯康星旧生研究基金会 制备有生物活性的α-β肽的方法
EP2630136A1 (en) * 2010-10-21 2013-08-28 Universität des Saarlandes Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
BR112019024534A2 (pt) * 2017-05-22 2020-06-09 Torrey Pines Inst For Molecular Studies composições, métodos de uso e métodos de tratamento

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0003732B1 (en) * 1978-02-01 1983-10-19 The Wellcome Foundation Limited Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof
GB2028317B (en) * 1978-08-15 1982-11-10 Pfizer Ltd 2-(imidazol-1-ylmethyl)-pyridine and -quinoline thromboxane synthetase inhibitors
US4634711A (en) * 1985-08-02 1987-01-06 Smithkline Beckman Corporation Pyridylalkyl imidazole-2-thiols
DE3811574A1 (de) * 1988-03-31 1989-10-19 Schering Ag N-substituierte imidazole, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
IL103229A0 (en) 1993-02-21
JP2568356B2 (ja) 1997-01-08
HU211261A9 (en) 1995-11-28
CA2078700C (en) 2005-09-13
SG43079A1 (en) 1997-10-17
TW222630B (da) 1994-04-21
MX9205365A (es) 1993-03-01
JPH05194491A (ja) 1993-08-03
CZ289692A3 (en) 1993-04-14
FI103887B (fi) 1999-10-15
HUT61993A (en) 1993-03-29
HU9202886D0 (en) 1992-11-30
RO109337B1 (ro) 1995-01-30
NO923653L (no) 1993-03-24
ZA927279B (en) 1994-03-23
NO923653D0 (no) 1992-09-21
ATE144509T1 (de) 1996-11-15
SK279224B6 (sk) 1998-08-05
KR100254085B1 (ko) 2000-09-01
NZ244420A (en) 1995-07-26
KR930006003A (ko) 1993-04-20
AU2522692A (en) 1993-03-25
FI924233A0 (fi) 1992-09-21
DE4131584A1 (de) 1993-03-25
FI103887B1 (fi) 1999-10-15
SK289692A3 (en) 1998-08-05
FI924233A (fi) 1993-03-24
IL103229A (en) 1996-09-12
EP0534904B1 (de) 1996-10-23
AU650569B2 (en) 1994-06-23
GR3021444T3 (en) 1997-01-31
RU2058312C1 (ru) 1996-04-20
CA2078700A1 (en) 1993-03-24
DE59207425D1 (de) 1996-11-28
CZ281675B6 (cs) 1996-12-11
EP0534904A1 (de) 1993-03-31
DK0534904T3 (da) 1996-11-18
ES2092666T3 (es) 1996-12-01
MY110450A (en) 1998-05-30

Similar Documents

Publication Publication Date Title
EP0955293B1 (en) Urea derivatives
RU2277094C2 (ru) Производные n-гетероциклических соединений, фармацевтическая композиция на их основе и способ лечения
TW201308B (da)
US4849424A (en) Pyrimidine derivatives
JPS63146874A (ja) インドール誘導体
AU684537B2 (en) Benzazepine derivative, pharmaceutical composition containing the same, and intermediate for the same
US5128343A (en) Derivatives of pyrimidinyl-piperazinyl-alkyl azoles with anxiolytic and/or tranquilizing activity
NO301162B1 (no) Imidazolylpyridinderivater
NO159930B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
HU196989B (en) Process for producing quinoline derivatives and pharmaceuticals comprising same
CZ411391A3 (en) Haloalkylphenyl alcohols, haloalkylphenyl ketones and hydrates thereof, process of their preparation and a pharmaceutical preparation containing them
FI91858C (fi) Menetelmä valmistaa farmakologisesti aktiivisia substituoituja 1H-imidatsoleja
RU2200737C2 (ru) Пиримидо[4,5-b]индолы и промежуточное соединение (варианты)
HUT53867A (en) Process for producing new pyrrolidine derivatives and pharmaceutical compositions comprising such compounds
US5856343A (en) Imidazolylmethyl-pyridines used for senile dementia
AU9762198A (en) Benzimidazole derivatives and pharmaceutically acceptable salts thereof
JPH03246282A (ja) トリアゾリルヒドラジド誘導体、その製造方法、およびその誘導体を活性成分とする抗狭心症または胃潰瘍防止用製剤組成物とその製造方法
FI62056B (fi) Foerfarande foer framstaellning av nya farmakologiskt verksamma substituerade nitrobenzofenonderivat
JPH07300455A (ja) 3−フェニルピロリジン誘導体
JPH0971564A (ja) ベンズアミドオキシム誘導体及びその医薬用途
JPH11130753A (ja) フェニルカルボン酸誘導体
IE904434A1 (en) "New thiophene derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them"
SE443560B (sv) Analogiforfarande for framstellning av 1-amino-legre alkyl-3,4-difenyl-1h-pyrazoler
US5246958A (en) Antihypertensive thiocarbamoylascetonitrile compounds
HUT68476A (en) Thiophene-2-carboxylic acid derivatives, pharmaceutical compositions containing them and process for their production

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees